PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF CAFFEINE - TOLERANCE TO PRESSOR EFFECTS

被引:76
作者
SHI, J
BENOWITZ, NL
DENARO, CP
SHEINER, LB
机构
[1] SAN FRANCISCO GEN HOSP,MED CTR,DIV CLIN PHARMACOL & EXPTL THERAPEUT,MED SERV,CLIN PHARMACOL UNIT,SAN FRANCISCO,CA 94110
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143
[4] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
关键词
D O I
10.1038/clpt.1993.3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We propose a parametric pharmacokinetic-pharmacodynamic model for caffeine that quantifies the development of tolerance to the pressor effect of the drug and characterizes the mean behavior and inter-individual variation of both pharmacokinetics and pressor effect. Our study in a small group of subjects indicates that acute tolerance develops to the pressor effect of caffeine and that both the pressor effect and tolerance occur after some time delay relative to changes in plasma caffeine concentration. The half-life of equilibration of effect with plasma caffeine concentration is about 20 minutes. The half-life of development and regression of tolerance is estimated to be about 1 hour, and the model suggests that tolerance, at its fullest, causes more than a 90% reduction of initial (nontolerant) effect. Whereas tolerance to the pressor effect of caffeine develops in habitual coffee drinkers, the pressor response is regained after relatively brief periods of abstinence. Because of the rapid development and regression of tolerance, the pressor response to caffeine depends on how much caffeine is consumed, the schedule of consumption, and the elimination half-life of caffeine.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 33 条
  • [1] STIMULATION OF CAFFEINE METABOLISM IN RAT BY 3-METHYLCHOLANTHRENE
    ALDRIDGE, A
    PARSONS, WD
    NEIMS, AH
    [J]. LIFE SCIENCES, 1977, 21 (07) : 967 - 974
  • [2] ADAPTATION OF BLOOD-PRESSURE TO CONTINUOUS HEAVY COFFEE-DRINKING IN YOUNG VOLUNTEERS - A DOUBLE-BLIND CROSSOVER STUDY
    AMMON, HPT
    BIECK, PR
    MANDALAZ, D
    VERSPOHL, EJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) : 701 - 706
  • [3] BEAL SL, 1990, NONMEM USERS GUIDES
  • [4] CLINICAL-PHARMACOLOGY OF CAFFEINE
    BENOWITZ, NL
    [J]. ANNUAL REVIEW OF MEDICINE, 1990, 41 : 277 - 288
  • [5] BERTRAND CA, 1978, NEW ENGL J MED, V229, P315
  • [6] CAFFEINE-CONTAINING BEVERAGES AND THE PREVALENCE OF HYPERTENSION
    BIRKETT, NJ
    LOGAN, AG
    [J]. JOURNAL OF HYPERTENSION, 1988, 6 : S620 - S622
  • [7] DOSE-DEPENDENCY OF CAFFEINE METABOLISM WITH REPEATED DOSING
    DENARO, CP
    BROWN, CR
    WILSON, M
    JACOB, P
    BENOWITZ, NL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 277 - 285
  • [8] BLOOD-PRESSURE RESPONSE TO THE 2ND CUP OF COFFEE
    GOLDSTEIN, IB
    SHAPIRO, D
    HUI, KK
    YU, JL
    [J]. PSYCHOSOMATIC MEDICINE, 1990, 52 (03): : 337 - 345
  • [9] THE EFFECTS OF CAFFEINE AND STRESS ON BLOOD-PRESSURE IN INDIVIDUALS WITH AND WITHOUT A FAMILY HISTORY OF HYPERTENSION
    GREENBERG, W
    SHAPIRO, D
    [J]. PSYCHOPHYSIOLOGY, 1987, 24 (02) : 151 - 156
  • [10] AGE AND PRIOR CAFFEINE USE ALTER THE CARDIOVASCULAR AND ADRENOMEDULLARY RESPONSES TO ORAL CAFFEINE
    IZZO, JL
    GHOSAL, A
    KWONG, T
    FREEMAN, RB
    JAENIKE, JR
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (07) : 769 - 773